Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812110 · ClinicalTrials.gov registry record · Phase 4
Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
A Phase 4 study, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 336
- Enrollment target
NCT00812110 is a Phase 4 study that has completed, run by Akron Children's Hospital. The registered enrollment target is 336 participants.
The verdict
NCT00812110, a Phase 4 study, has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 336 participants
- Enrollment target
Study Summary
We hypothesize that when offered influenza vaccine at little or no cost, in a setting where the value of the vaccine is connected to one's high risk child, vaccination rates for parents will approach 90-95%, similar to rates obtained in the Neonatal Intensive Care Unit environment.
Interventions
- DRUG Influenzae vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00812110
The ClinicalTrials.gov registry entry for NCT00812110 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 336 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akron Children's Hospital, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Influenzae vaccine is the first listed.
NCT00812110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00812110 about?
NCT00812110 is a clinical study titled "Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home". We hypothesize that when offered influenza vaccine at little or no cost, in a setting where the value of the vaccine is connected to one's high risk child, vaccination rates for parents will approach 90-95%, similar to rates obtained in the Neonatal Intensive Care Unit environment.
What is the current status of trial NCT00812110?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 336 participants. The study started on 2008-12. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00812110?
The interventions under investigation include: Influenzae vaccine (DRUG).
Who is sponsoring clinical trial NCT00812110?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.